|
|
Article: Novuspharma SpA Announces Financial Results for the Third Quarter Ended 30 September 2001.
- Article from:
- PR Newswire
- Article date:
- November 13, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- Co-Founders and Managers Form Syndicate and Extend Lock-Up Agreement -
BRESSO, Italy, Nov. 13 /PRNewswire/ --
Novuspharma SpA (Nuovo Mercato: NOV.MI), a biotechnology company focused on cancer, today announces financial results for the third quarter ended 30 September 2001 and an update on clinical development. The Company also announces that its co-founders and managers, who together own approximately 10% of Novuspharma, have formed a syndicate and extended their lock-up agreement on a staged basis until November 2004.
Highlights:
* BBR 2778 commenced recruitment for a US Phase II combination study; US
Phase III studies ...